Results 51 to 60 of about 9,052 (66)
Some of the next articles are maybe not open access.

Pharmaceutical and biological characterisation of a doxorubicin-polymer conjugate (PK1) entrapped in sorbitan monostearate Span 60 niosomes

International Journal of Pharmaceutics, 1997
Ijeoma Uchegbu   +2 more
exaly  

Autographa californica multiple nucleopolyhedrovirus PK1 is a factor that regulates high-level expression of very late genes in viral infection

Virology, 2017
Shuling Zhao, Changyong Liang
exaly  

Role of enhanced ceramide generation in DNA damage and cell death in chemical hypoxic injury to LLC-PK1 cells

Kidney International, 1998
Gur P Kaushal, Sudhir Shah, Norishi Ueda
exaly  

The Impact of Endogenous Breast Cancer Resistance Protein on Human P-Glycoprotein-Mediated Transport Assays Using LLC-PK1 Cells Transfected With Human P-Glycoprotein

Journal of Pharmaceutical Sciences, 2019
Kenji Tabata
exaly  

QSAR Prediction of Passive Permeability in the LLC-PK1 Cell Line: Trends in Molecular Properties and Cross-Prediction of Caco-2 Permeabilities

Molecular Informatics, 2012
Edward C Sherer   +2 more
exaly  

Inhibition of Intracellular ROS Accumulation by Formononetin Attenuates Cisplatin-Mediated Apoptosis in LLC-PK1 Cells

International Journal of Molecular Sciences, 2018
Ji Hoon Song, Ki Sung Kang
exaly  

Toluene and p‐Xylene Induced LLC‐PK1 Apoptosis

Drug and Chemical Toxicology, 2004
Saeed Al-Ghamdi   +2 more
exaly  

Membrane Transport Mechanisms of Quinidine and Procainamide in Renal LLC-PK1 and Intestinal LS180 Cells

Biological and Pharmaceutical Bulletin, 2010
Kazuya Ishida   +2 more
exaly  

Inhibition of Na,K-ATPase Activates PI3 Kinase and Inhibits Apoptosis in LLC-PK1 Cells

Biochemical and Biophysical Research Communications, 2001
Tamás Balla   +2 more
exaly  

A comparison of BGM and LLC-PK1 cells for the evaluation of nephrotoxicity

Drug and Chemical Toxicology, 2012
Emma Martínez-Lopez   +2 more
exaly  
previous   4  5  6  7  

Home - About - Disclaimer - Privacy